Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Revenue

Universal Vision Biotechnology had revenue of 1.09B TWD in the quarter ending March 31, 2026, a decrease of -2.97%. This brings the company's revenue in the last twelve months to 4.17B, down -2.56% year-over-year. In the year 2025, Universal Vision Biotechnology had annual revenue of 4.20B, down -0.57%.

• Revenue (ttm): 4.17B
• Revenue Growth: -2.56%
• P/S Ratio: 2.80
• Revenue / Employee: 10.40M
• Employees: 401
• Market Cap: 11.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.20B	-24.22M	-0.57%
Dec 31, 2024	4.23B	146.05M	3.58%
Dec 31, 2023	4.08B	588.20M	16.83%
Dec 31, 2022	3.49B	862.26M	32.76%
Dec 31, 2021	2.63B	578.66M	28.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error